ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
transtar
|
12 |
4.7K |
1 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
transtar
|
12 |
4.7K |
3 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
12
|
4.7K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
transtar
|
12 |
4.7K |
3 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
12
|
4.7K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
transtar
|
160 |
74K |
6 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
160
|
74K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
ACW Chart
|
|
transtar
|
42 |
22K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
42
|
22K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen prioritizes Alzheimers Disease & Depression
|
|
transtar
|
35 |
16K |
0 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
35
|
16K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW announces positive XanaMIA results for Xanamem
|
|
transtar
|
33 |
17K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
33
|
17K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
transtar
|
47 |
25K |
0 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
47
|
25K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
transtar
|
47 |
25K |
0 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
47
|
25K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
transtar
|
47 |
25K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
47
|
25K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Prof Paul Rolan as Chief Medical Officer
|
|
transtar
|
5 |
2.7K |
0 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
5
|
2.7K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Prof Paul Rolan as Chief Medical Officer
|
|
transtar
|
5 |
2.7K |
2 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
5
|
2.7K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
transtar
|
2 |
1.5K |
1 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Blatant manipulation
|
|
transtar
|
17 |
6.9K |
3 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
17
|
6.9K
|
3
|
|
Charts
|
ACW |
Re:
Chart
|
|
transtar
|
267 |
130K |
1 |
20/01/22 |
20/01/22 |
Charts
|
267
|
130K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW Strategic Collaboration with Oxford Uni Researchers
|
|
transtar
|
20 |
6.5K |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
20
|
6.5K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW Strategic Collaboration with Oxford Uni Researchers
|
|
transtar
|
20 |
6.5K |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
20
|
6.5K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW Strategic Collaboration with Oxford Uni Researchers
|
|
transtar
|
20 |
6.5K |
3 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
20
|
6.5K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW Strategic Collaboration with Oxford Uni Researchers
|
|
transtar
|
20 |
6.5K |
1 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
20
|
6.5K
|
1
|
|
Charts
|
ACW |
Re:
Chart
|
|
transtar
|
267 |
130K |
2 |
06/12/21 |
06/12/21 |
Charts
|
267
|
130K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
News: ACW Actinogen Medical Says Got Commitments For A$12 Mln Via Oversubscribed Institutional...
|
|
transtar
|
3 |
1.5K |
2 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
3
|
1.5K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson to Accelerate Engineering for Paradox Lithium Plant
|
|
transtar
|
69 |
29K |
7 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
69
|
29K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
transtar
|
45 |
16K |
3 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
45
|
16K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
transtar
|
45 |
16K |
0 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
45
|
16K
|
0
|
|
Charts
|
ACW |
Re:
Chart
|
|
transtar
|
267 |
130K |
5 |
29/10/21 |
29/10/21 |
Charts
|
267
|
130K
|
5
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
1 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
1.4K
|
508K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Closes SPP Oversubscribed
|
|
transtar
|
146 |
43K |
2 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
146
|
43K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Closes SPP Oversubscribed
|
|
transtar
|
146 |
43K |
1 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
146
|
43K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Closes SPP Oversubscribed
|
|
transtar
|
146 |
43K |
3 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
146
|
43K
|
3
|
|
ASX - By Stock
|
AUZ |
Re:
News: AUZ Australian Mines Ltd agrees deal with LG Energy for nickel-cobalt supply
|
|
transtar
|
2 |
1.0K |
2 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Binding offtake agreement signed with LG Energy Solution
|
|
transtar
|
1.6K |
558K |
1 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
1.6K
|
558K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Presentation - Spark Plus Mining Day
|
|
transtar
|
64 |
22K |
4 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt Joins European Raw Materials Alliance
|
|
transtar
|
41 |
15K |
2 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
41
|
15K
|
2
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt Joins European Raw Materials Alliance
|
|
transtar
|
41 |
15K |
1 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
41
|
15K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt Joins European Raw Materials Alliance
|
|
transtar
|
41 |
15K |
5 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
41
|
15K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen to present at ********* Small Cap Webinar
|
|
transtar
|
9 |
2.8K |
1 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen to present at ********* Small Cap Webinar
|
|
transtar
|
9 |
2.8K |
2 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
9
|
2.8K
|
2
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
transtar
|
10 |
5.1K |
2 |
31/07/21 |
31/07/21 |
ASX - By Stock
|
10
|
5.1K
|
2
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Completion of the ZG Group Transaction
|
|
transtar
|
153 |
57K |
5 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
153
|
57K
|
5
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
3 |
24/07/21 |
24/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
3
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
5 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
5
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
3 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
3
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
3 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
3
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
9 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
New Alzheimer's drug may be a catastrophe in the making
|
|
transtar
|
42 |
16K |
7 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
42
|
16K
|
7
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
1 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL
|
|
transtar
|
1.4K |
508K |
2 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
1.4K
|
508K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Previous Xanamem multiple ascending dose study
|
|
transtar
|
10 |
3.9K |
1 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
10
|
3.9K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
investors/shorters gone??
|
|
transtar
|
27 |
10K |
1 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
27
|
10K
|
1
|
|
Charts
|
ACW |
Re:
Chart
|
|
transtar
|
267 |
130K |
4 |
01/07/21 |
01/07/21 |
Charts
|
267
|
130K
|
4
|
|